Article: company discovers drug that works on rare seizure condition, but not the mass-market application they intended it for. Drug sales are "only" $14 million.

Business solution: stop making the drug, let those patients go back to having 6 seizures an hour.

https://www.washingtonpost.com/business/econo...1ab729d86f